BioTrinity is described as Europe’s leading investment and biopartnering conference, providing a unique platform for pharmaceutical, R&D and associated companies to discuss investment and partnering opportunities. This year’s theme is the ‘Vision for Life Sciences 2030’ and will focus on industry development trends.
Our CEO, Dr. John McKenzie, will be presenting a brief company overview of Wickham Laboratories at 11:30AM on Tuesday, April 26th as part of the later stage showcase group. Please join us for this presentation or arrange a meeting directly if you would like to discuss any potential business collaborations.
